VN Brno – Risankizumab

Economic Operator with Whom the Contract Has Been Concluded


Show detail
DetailS-002314/2411. 07. 2024AbbVie s.r.o.3 983 127,463 556 363,803 983 127,463 556 363,80CZK

Published Documents


Show detail
DetailPisemna zprava zadavatele Risankizumab.docxPísemná zpráva zadavatele25. 07. 2024 08:40Dokument není zavirovaný

List of Participants


Show detail
DetailAbbVie s.r.o.PrahaYes